IL6 and myocardial ischemia: Interestingly, although IL-6 is the most studied inflammatory biomarker in IHD and we and others find it to be higher in acute presentations [37–40], it is not included in the final model as it is not informative to discriminate between obstructive and non-obstructive CAD, possibly because it participates to the pathogenesis of both types of CAD.